MedPath
NMPA Approval

Erythromycin Estolate Granules

国药准字H20094034

October 10, 2024

Drug Information

依托红霉素颗粒

笴力克

颗粒剂

按红霉素计75mg(7.5万单位)

化学药品

October 10, 2024

Company Information

Applicant Company

湖北省荆州市沙市区观音垱镇汉沙街33号

Manufacturing Company

湖北省荆州市沙市区观音垱镇汉沙街33号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

依托红霉素颗粒 - NMPA 批准文号 | MedPath